Los Angeles Capital Management
TSVT

Los Angeles Capital Management’s 2seventy bio TSVT Stock Holding History

Los Angeles Capital Management’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-26,749
Closed -$273K – 1295
2023
Q1 		$273K Sell
26,749
-510
-2% -$5.83K ﹤0.01% 1039
2022
Q4 		$255K Hold
27,259
– – ﹤0.01% 1086
2022
Q3 		$397K Hold
27,259
– – ﹤0.01% 989
2022
Q2 		$360K Buy
+27,259
New +$371K ﹤0.01% 1092

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Los Angeles Capital Management's TSVT Position: Q2 2023 in Review

Los Angeles Capital Management sold out of 2seventy bio (TSVT) in Q2 2023, closing a stake of 26,749 shares — an estimated $273K sold.

Los Angeles Capital Management first reported a position in TSVT in Q2 2022 and held it in 4 quarters. The position peaked at $397K in Q3 2022. 149 funds tracked by Wall St. Rank hold TSVT as of Q2 2023.

  • Los Angeles Capital Management reported no remaining 2seventy bio position as of Q2 2023 after selling out during the quarter.
  • Los Angeles Capital Management sold 26,749 2seventy bio shares in Q2 2023, an estimated $273K.
  • Los Angeles Capital Management first reported a position in 2seventy bio in Q2 2022 and held it in 4 quarters.
  • Los Angeles Capital Management's 2seventy bio position peaked at $397K in Q3 2022.
  • 149 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2023.

Based on Los Angeles Capital Management's 13F filing for Q2 2023, filed 3 Aug 2023.